These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8151795)

  • 1. A protease activation mutant, MVCES1, as a safe and potent live vaccine derived from currently prevailing Sendai virus.
    Wang XL; Itoh M; Hotta H; Homma M
    J Virol; 1994 May; 68(5):3369-73. PubMed ID: 8151795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a protease activation mutant of Sendai virus as a potent live vaccine.
    Maru M; Haraguchi M; Sato K; Hotta H; Homma M
    Vet Microbiol; 1992 Jan; 30(1):1-12. PubMed ID: 1311131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumopathogenicity of a Sendai virus protease-activation mutant, TCs, which is sensitive to trypsin and chymotrypsin.
    Itoh M; Ming TD; Hayashi T; Mochizuki Y; Homma M
    J Virol; 1990 Nov; 64(11):5660-4. PubMed ID: 2170692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosol vaccination with a sendai virus temperature-sensitive mutant (HVJ-pB) derived from persistently infected cells.
    Iwata H; Tagaya M; Matsumoto K; Miyadai T; Yokochi T; Kimura Y
    J Infect Dis; 1990 Aug; 162(2):402-7. PubMed ID: 1695654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pneumotropic revertants derived from a pantropic mutant, F1-R, of Sendai virus.
    Tashiro M; James I; Karri S; Wahn K; Tobita K; Klenk HD; Rott R; Seto JT
    Virology; 1991 Sep; 184(1):227-34. PubMed ID: 1651590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a temperature-sensitive Sendai virus vaccine in hamsters.
    Tagaya M; Mori I; Miyadai T; Kimura Y; Ito H; Nakakuki K
    Lab Anim Sci; 1995 Jun; 45(3):233-8. PubMed ID: 7650890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuated Human Parainfluenza Virus Type 1 (HPIV1) Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus (RSV) as a Bivalent HPIV1/RSV Vaccine.
    Mackow N; Amaro-Carambot E; Liang B; Surman S; Lingemann M; Yang L; Collins PL; Munir S
    J Virol; 2015 Oct; 89(20):10319-32. PubMed ID: 26223633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of mice from wild-type Sendai virus infection by a trypsin-resistant mutant, TR-2.
    Tashiro M; Homma M
    J Virol; 1985 Jan; 53(1):228-34. PubMed ID: 2981341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immunity induced in mice after vaccination with a protease activation mutant, TR-2, of Sendai virus.
    Tashiro M; Fujii Y; Nakamura K; Homma M
    J Virol; 1988 Jul; 62(7):2490-7. PubMed ID: 2836627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of novel hemagglutinin-neuraminidase inhibitors BCX 2798 and BCX 2855 against human parainfluenza viruses in vitro and in vivo.
    Alymova IV; Taylor G; Takimoto T; Lin TH; Chand P; Babu YS; Li C; Xiong X; Portner A
    Antimicrob Agents Chemother; 2004 May; 48(5):1495-502. PubMed ID: 15105096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumopathogenicity in mice of a Sendai virus mutant, TSrev-58, is accompanied by in vitro activation with trypsin.
    Mochizuki Y; Tashiro M; Homma M
    J Virol; 1988 Aug; 62(8):3040-2. PubMed ID: 2839720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective efficacy of intranasal vaccination with subunit Sendai virus vaccine in mice.
    Ito H; Matumoto M
    Jpn J Exp Med; 1986 Jun; 56(3):125-9. PubMed ID: 3020282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single amino acid change at the cleavage site of the fusion protein is responsible for both enhanced chymotrypsin sensitivity and trypsin resistance of a Sendai virus mutant, TR-5.
    Itoh M; Homma M
    J Gen Virol; 1988 Nov; 69 ( Pt 11)():2907-11. PubMed ID: 2846765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of mice against virulent virus infection by a temperature-sensitive mutant derived from an HVJ (Sendai virus) carrier culture.
    Kimura Y; Aoki H; Shimokata K; Ito Y; Takano M; Hirabayashi N; Norrby E
    Arch Virol; 1979; 61(4):297-304. PubMed ID: 229796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutation of the HANA protein of Sendai virus by passage in eggs.
    Itoh M; Wang XL; Suzuki Y; Homma M
    Virology; 1992 Sep; 190(1):356-64. PubMed ID: 1326808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live bivalent vaccine for parainfluenza and influenza virus infections.
    Maeda Y; Hatta M; Takada A; Watanabe T; Goto H; Neumann G; Kawaoka Y
    J Virol; 2005 Jun; 79(11):6674-9. PubMed ID: 15890905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of inactivated virus vaccine on Sendai virus infection in rats.
    Tsukui M; Ito H; Tada M; Nakata M; Miyajima H; Fujiwara K
    Lab Anim Sci; 1982 Apr; 32(2):143-6. PubMed ID: 6281572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Susceptibility of mice to Sendai virus infection].
    Iwai H
    Jikken Dobutsu; 1984 Jul; 33(3):275-82. PubMed ID: 6094220
    [No Abstract]   [Full Text] [Related]  

  • 19. Protection of mice by a protease inhibitor, aprotinin, against lethal Sendai virus pneumonia.
    Hayashi T; Hotta H; Itoh M; Homma M
    J Gen Virol; 1991 Apr; 72 ( Pt 4)():979-82. PubMed ID: 1707950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A field isolate of Sendai virus: its high virulence to mice and genetic divergence form prototype strains.
    Sakaguchi T; Kiyotani K; Sakaki M; Fujii Y; Yoshida T
    Arch Virol; 1994; 135(1-2):159-64. PubMed ID: 8198441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.